Sanne Y. Apeldoorn-Smith
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: March 25, 2026
Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial.
Journal: Journal of affective disorders
Published: February 12, 2026
ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.
Journal: Pharmacogenomics
Published: January 21, 2026
ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine.
Journal: Pharmacogenomics
Published: January 21, 2026
Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach.
Journal: Journal of psychiatric research
Published: July 16, 2025
Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program.
Journal: Journal of psychopharmacology (Oxford, England)
Published: April 26, 2025
The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine.
Journal: The pharmacogenomics journal
Published: April 09, 2025
Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 07, 2025
Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients With Treatment-Resistant Depression: A Case Series.
Journal: The journal of ECT
Published: January 24, 2025
Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment.
Journal: European journal of pharmacology
Published: December 18, 2024
Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension.
Journal: Molecular psychiatry
Published: September 20, 2023
Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
Journal: Psychopharmacology
Published: June 17, 2023
Last Updated: 09/26/2026